Biomanufacture of human platelets for transfusion: Rationale and approaches

Experimental Hematology

Volumn 42, Issue 5, 2014, Pages 332-346

  Lee, Eun ju ^a,b   Godara, Pankaj ^a,b   Haylock, David ^a,b  

^a CSIRO   (Australia)

^b Australian Regenerative Medicine Institute and Department of Anatomy and Developmental Biology   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

BIOENGINEERING; BIOREACTOR; BLOOD CLOTTING; BONE MARROW; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSFORMATION; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOBLAST; MEGAKARYOPOIESIS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL EXPANSION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS; UMBILICAL CORD BLOOD;

BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; THROMBOPOIESIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84901047714     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2014.02.002     Document Type: Review

References (158)

1. Emerson S.G., Palsson B.O., Clarke M.F. The construction of high efficiency human bone marrow tissue exvivo. J Cell Biochem 1991, 45:268-272.
2. Abbot S. The three "R"s of blood transfusion in 2020; routine, reliable and robust. Clin Lab Med 2010, 30:405-417.
3. Cabrita G.J.M., Ferreira B.S., da Silva C.L., Gonçalves R., Almeida-Porada G., Cabral J.M.S. Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol 2003, 21:233-240.
4. Housler G.J., Miki T., Schmelzer E., et al. Compartmental hollow fiber capillary membrane-based bioreactor technology for invitro studies on red blood cell lineage direction of hematopoietic stem cells. Tissue Eng Part C Methods 2012, 18:133-142.
5. Neildez-Nguyen T.M., Wajcman H., Marden M.C., et al. Human erythroid cells produced exvivo at large scale differentiate into red blood cells invivo. Nat Biotechnol 2002, 20:467-472.
6. Giarratana M.C., Kobari L., Lapillonne H., et al. Exvivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005, 23:69-74.
7. Harker L.A., Finch C.A. Thrombokinetics in man. J Clin Invest 1969, 48:963-974.
8. Jackson C.W., Edwards C.C. Biphasic thrombopoietic response to severe hypobaric hypoxia. Br J Haematol 1977, 35:233-244.
9. Bruno E., Hoffman R. Human megakaryocyte progenitor cells. Semin Hematol 1998, 35:183-191.
10. Long M.W. Megakaryocyte differentiation events. Semin Hematol 1998, 35:192-199.
11. Kaushansky K. Thrombopoietin. N Engl J Med 1998, 339:746-754.
12. Kaushansky K., Lok S., Holly R.D., et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994, 369:568-571.
13. Debili N., Issaad C., Masse J.M., et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992, 80:3022-3035.
14. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005, 115:3339-3347.
15. Gaydos L.A., Mantel N., Freireich E.J. Quantitative relation between platelet count and hemorrhage in patients with acute leukemia. New Engl J Med 1962, 266:905-909.
16. Salacz M.E., Lankiewicz M.W., Weissman D.E. Management of thrombocytopenia in bone marrow failure: a review. J Palliat Med 2007, 10:236-244.
17. Slichter S.J., Kaufman R.M., Assmann S.F., et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010, 362:600-613.
18. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004, 351:2276-2285.
19. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004, 351:2265-2275.
20. Timmins N.E., Palfreyman E., Marturana F., et al. Clinical scale exvivo manufacture of neutrophils from hematopoietic progenitor cells. Biotechnol Bioeng 2009, 104:832-840.
21. Csaszar E., Cohen S., Zandstra P.W. Blood stem cell products: toward sustainable benchmarks for clinical translation. Bioessays 2013, 35:201-210.
22. Brand A., Novotny V., Tomson B. Platelet transfusion therapy: from 1973 to 2005. Hum Immunol 2006, 67:413-418.
23. Stroncek D.F., Rebulla P. Platelet transfusions. Lancet 2007, 370:427-438.
24. Heddle N.M. Optimal timing and dosing of platelet transfusions. Isbt Sci Series 2010, 5:88-94.
25. Consensus conference. Platelet transfusion therapy. JAMA 1987, 257:1777-1780.
26. Kelsey P., Murphy M.F., Brown M., et al. Guidelines for the use of platelet transfusions. Br J Haematol 2003, 122:10-23.
27. Heddle N.M., Cook R.J., Sigouin C., et al. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion 2006, 46:903-911.
28. Yamada E. The fine structure of the megakaryocyte in the mouse spleen. Acta Anat (Basel) 1957, 29:267-290.
29. Kosaki G. Invivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets?. Int J Hematol 2005, 81:208-219.
30. Kosaki G. Platelet production by megakaryocytes: protoplatelet theory justifies cytoplasmic fragmentation model. Int J Hematol 2008, 88:255-267.
31. Becker R.P., De Bruyn P.P. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat 1976, 145:183-205.
32. Radley J.M., Scurfield G. The mechanism of platelet release. Blood 1980, 56:996-999.
33. Radley J.M., Haller C.J. The demarcation membrane system of the megakaryocyte: a misnomer?. Blood 1982, 60:213-219.
34. Junt T., Schulze H., Chen Z., et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007, 317:1767-1770.
35. Zhang L., Orban M., Lorenz M., et al. A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med 2012, 209:2165-2181.
36. Tavassoli M., Aoki M. Migration of entire megakaryocytes through the marrow-blood barrier. Br J Haematol 1981, 48:25-29.
37. Haylock D.N., Horsfall M.J., Dowse T.L., et al. Increased recruitment of hematopoietic progenitor cells underlies the exvivo expansion potential of FLT3 ligand. Blood 1997, 90:2260-2272.
38. Piacibello W., Sanavio F., Severino A., et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after exvivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999, 93:3736-3749.
39. Gammaitoni L., Bruno S., Sanavio F., et al. Exvivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol 2003, 31:261-270.
40. -) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol 1997, 158:5169-5177.
41. - cells with preserved ability to engraft SCID-hu bone. Blood 1998, 91:1206-1215.
42. + umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines. J Hematother Stem Cell Res 1999, 8:609-618.
43. Zhang C.C., Lodish H.F. Cytokines regulating hematopoietic stem cell function. Curr Opin Hematol 2008, 15:307-311.
44. Zhang C.C., Kaba M., Iizuka S., Huynh H., Lodish H.F. Angiopoietin-like 5 and IGFBP2 stimulate exvivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 2008, 111:3415-3423.
45. Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R.L., Bernstein I.D. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010, 16:232-236.
46. Walasek M.A., van Os R., de Haan G. Hematopoietic stem cell expansion: challenges and opportunities. Ann N Y Acad Sci 2012, 1266:138-150.
47. Haylock D.N., Nilsson S.K. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2007, 2:324-335.
48. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
49. Jones D.L., Wagers A.J. No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol 2008, 9:11-21.
50. Hofmeister C.C., Zhang J., Knight K.L., Le P., Stiff P.J. Exvivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007, 39:11-23.
51. Flanagan J.G., Chan D.C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991, 64:1025-1035.
52. Doran M.R., Markway B.D., Aird I.A., et al. Surface-bound stem cell factor and the promotion of hematopoietic cell expansion. Biomaterials 2009, 30:4047-4052.
53. Doheny J.G., Jervis E.J., Guarna M.M., Humphries R.K., Warren R.A., Kilburn D.G. Cellulose as an inert matrix for presenting cytokines to target cells: production and properties of a stem cell factor-cellulose-binding domain fusion protein. Biochem J 1999, 339(Pt 2):429-434.
54. Jervis E.J., Guarna M.M., Doheny J.G., Haynes C.A., Kilburn D.G. Dynamic localization and persistent stimulation of factor-dependent cells by a stem cell factor/cellulose binding domain fusion protein. Biotechnol Bioeng 2005, 91:314-324.
55. Erben U., Thiel E., Notter M. Differential effects of a stem cell factor-immunoglobulin fusion protein on malignant and normal hematopoietic cells. Cancer Res 1999, 59:2924-2930.
56. Miyazawa K., Williams D.A., Gotoh A., Nishimaki J., Broxmeyer H.E., Toyama K. Membrane-bound steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 1995, 85:641-649.
57. Varnum-Finney B., Brashem-Stein C., Bernstein I.D. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 2003, 101:1784-1789.
58. Delaney C., Varnum-Finney B., Aoyama K., Brashem-Stein C., Bernstein I.D. Dose-dependent effects of the Notch ligand Delta1 on exvivo differentiation and invivo marrow repopulating ability of cord blood cells. Blood 2005, 106:2693-2699.
59. Peerani R., Zandstra P.W. Enabling stem cell therapies through synthetic stem cell-niche engineering. J Clin Invest 2010, 120:60-70.
60. Vazin T., Schaffer D.V. Engineering strategies to emulate the stem cell niche. Trends Biotechnol 2010, 28:117-124.
61. Dellatore S.M., Garcia A.S., Miller W.M. Mimicking stem cell niches toincrease stem cell expansion. Curr Opin Biotechnol 2008, 19:534-540.
62. Gilbert P.M., Blau H.M. Engineering a stem cell house into a home. Stem Cell Res Ther 2011, 2:3.
63. Lutolf M.P., Blau H.M. Artificial stem cell niches. Adv Mater 2009, 21:3255-3268.
64. Chua K.N., Chai C., Lee P.C., Ramakrishna S., Leong K.W., Mao H.Q. Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells. Exp Hematol 2007, 35:771-781.
65. Holst J., Watson S., Lord M.S., et al. Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat Biotechnol 2010, 28:1123-1128.
66. Haylock D.N., Williams B., Johnston H.M., et al. Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum. Stem Cells 2007, 25:1062-1069.
67. Grassinger J., Haylock D.N., Williams B., Olsen G.H., Nilsson S.K. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood 2010, 116:3185-3196.
68. Panuganti S., Papoutsakis E.T., Miller W.M. Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential. Cytotherapy 2010, 12:767-782.
69. Mohyeldin A., Garzon-Muvdi T., Quinones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010, 7:150-161.
70. Cipolleschi M.G., Dello Sbarba P., Olivotto M. The role of hypoxia inthe maintenance of hematopoietic stem cells. Blood 1993, 82:2031-2037.
71. Eliasson P., Jonsson J.I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 2010, 222:17-22.
72. Winkler I.G., Barbier V., Wadley R., Zannettino A.C., Williams S., Levesque J.P. Positioning of bone marrow hematopoietic and stromal cells relative to blood flow invivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. Blood 2010, 116:375-385.
73. Yang H., Miller W.M., Papoutsakis E.T. Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells 2002, 20:320-328.
74. Mostafa S.S., Miller W.M., Papoutsakis E.T. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol 2000, 111:879-889.
75. Hermitte F., Brunet de la Grange P., Belloc F., Praloran V., Ivanovic Z. Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells. Stem Cells 2006, 24:65-73.
76. Shima H., Takubo K., Iwasaki H., et al. Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice. Biochem Biophys Res Commun 2009, 378:467-472.
77. Dao M.A., Creer M.H., Nolta J.A., Verfaillie C.M. Biology of umbilical cord blood progenitors in bone marrow niches. Blood 2007, 110:74-81.
78. Tursky M.L., Collier F.M., Ward A.C., Kirkland M.A. Systematic investigation of oxygen and growth factors in clinically valid exvivo expansion of cord blood CD34(+) hematopoietic progenitor cells. Cytotherapy 2012, 14:679-685.
79. Nombela-Arrieta C., Pivarnik G., Winkel B., et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat Cell Biol 2013, 15:533-543.
80. Madlambayan G.J., Rogers I., Kirouac D.C., et al. Dynamic changes in cellular and microenvironmental composition can be controlled to elicit invitro human hematopoietic stem cell expansion. Exp Hematol 2005, 33:1229-1239.
81. Hoffman R. Progress in the development of systems for invitro expansion of human hematopoietic stem cells. Curr Opin Hematol 1999, 6:184.
82. Kirouac D.C., Madlambayan G.J., Yu M., Sykes E.A., Ito C., Zandstra P.W. Cell-cell interaction networks regulate blood stem and progenitor cell fate. Mol Syst Biol 2009, 5:293.
83. Csaszar E., Kirouac D.C., Yu M., et al. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 2012, 10:218-229.
84. Boitano A.E., de Lichtervelde L., Snead J.L., Cooke M.P., Schultz P.G. An image-based screen identifies a small molecule regulator of megakaryopoiesis. Proc Natl Acad Sci U S A 2012, 109:14019-14023.
85. Flores-Guzman P., Martinez-Jaramillo G., Montesinos J.J., Valencia I., Mayani H. Growth kinetics of progenitor cell-enriched hematopoietic cell populations in long-term liquid cultures under continuous removal of mature cells. Cytotherapy 2006, 8:299-307.
86. Madlambayan G.J., Rogers I., Purpura K.A., et al. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant 2006, 12:1020-1030.
87. Lok S., Kaushansky K., Holly R.D., et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production invivo. Nature 1994, 369:565-568.
88. de Sauvage F.J., Hass P.E., Spencer S.D., et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994, 369:533-538.
89. Wendling F., Maraskovsky E., Debili N., et al. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994, 369:571-574.
90. Broudy V.C., Lin N.L., Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy invitro. Blood 1995, 85:1719-1726.
91. Debili N., Wendling F., Katz A., et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995, 86:2516-2525.
92. Norol F., Vitrat N., Cramer E., et al. Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 1998, 91:830-843.
93. Kie J.H., Yang W.I., Lee M.K., et al. Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during exvivo expansion of human cord blood CD34+ cells using thrombopoietin. Stem Cells 2002, 20:73-79.
94. Lazzari L., Henschler R., Lecchi L., Rebulla P., Mertelsmann R., Sirchia G. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate exvivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica 2000, 85:25-30.
95. Wang J.F., Liu Z.Y., Groopman J.E. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 1998, 92:756-764.
96. Hamada T., Mohle R., Hesselgesser J., et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 1998, 188:539-548.
97. Lane W.J., Dias S., Hattori K., et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000, 96:4152-4159.
98. Avecilla S.T., Hattori K., Heissig B., et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004, 10:64-71.
99. Hodohara K., Fujii N., Yamamoto N., Kaushansky K. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 2000, 95:769-775.
100. Fujiki H., Kimura T., Minamiguchi H., et al. Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol 2002, 30:1373-1380.
101. Su R.J., Li K., Yang M., et al. Platelet-derived growth factor enhances exvivo expansion of megakaryocytic progenitors from human cord blood. Bone Marrow Transplant 2001, 27:1075-1080.
102. Proulx C., Boyer L., Hurnanen D.R., Lemieux R. Preferential exvivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res 2003, 12:179-188.
103. Proulx C., Dupuis N., St-Amour I., Boyer L., Lemieux R. Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. Biotechnol Bioeng 2004, 88:675-680.
104. Cortin V., Garnier A., Pineault N., Lemieux R., Boyer L., Proulx C. Efficient invitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol 2005, 33:1182-1191.
105. Pineault N., Boucher J.F., Cayer M.P., et al. Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev 2008, 17:483-493.
106. Boyer L., Robert A., Proulx C., Pineault N. Increased production ofmegakaryocytes near purity from cord blood CD34+ cells using a short two-phase culture system. J Immunol Methods 2008, 332:82-91.
107. Pineault N., Cortin V., Boyer L., et al. Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture. Cytotherapy 2011, 13:467-480.
108. Box D.E.P., Draper N.R. Empirical model-building and response surfaces 1987, John Wiley & Sons, New York.
109. Williams J.L., Pipia G.G., Datta N.S., Long M.W. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal exvivo expansion of megakaryocyte precursor cells. Blood 1998, 91:4118-4126.
110. van Hensbergen Y., Schipper L.F., Brand A., et al. Exvivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol 2006, 34:943-950.
111. Chen T.W., Hwang S.M., Chu I.M., Hsu S.C., Hsieh T.B., Yao C.L. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure. Exp Hematol 2009, 37:1330-1339.
112. Guerriero R., Mattia G., Testa U., et al. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 2001, 97:2587-2595.
113. Allen B.L., Filla M.S., Rapraeger A.C. Role of heparan sulfate as a tissue-specific regulator of FGF4 and FGF receptor recognition. JCell Biol 2001, 155:845-858.
114. Behnke O. An electron microscope study of the megakaryocyte of the rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat. J Ultrastruct Res 1968, 24:412-433.
115. Shaklai M., Tavassoli M. Demarcation membrane system in rat megakaryocyte and the mechanism of platelet formation: a membrane reorganization process. J Ultrastruct Res 1978, 62:270-285.
116. Machlus K.R., Italiano J.E. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 2013, 201:785-796.
117. Schulze H., Korpal M., Hurov J., et al. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood 2006, 107:3868-3875.
118. Levine R.F., Hazzard K.C., Lamberg J.D. The significance of megakaryocyte size. Blood 1982, 60:1122-1131.
119. Mattia G., Vulcano F., Milazzo L., et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002, 99:888-897.
120. Guerriero R., Testa U., Gabbianelli M., et al. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 1995, 86:3725-3736.
121. Miyazaki R., Ogata H., Iguchi T., et al. Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol 2000, 108:602-609.
122. van den Oudenrijn S., Bruin M., Folman C.C., et al. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br J Haematol 2000, 110:441-448.
123. Bornstein R., García-Vela J., Gilsanz F., Auray C., Calés C. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol 2001, 114:458-465.
124. Giammona L.M., Fuhrken P.G., Papoutsakis E.T., Miller W.M. Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes. Br J Haematol 2006, 135:554-566.
125. Giammona L.M., Panuganti S., Kemper J.M., et al. Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Exp Hematol 2009, 37:1340-1352 e1343.
126. Avanzi M.P., Chen A., He W., Mitchell W.B. Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. Transfusion 2012, 52:2406-2413.
127. Leysi-Derilou Y., Duchesne C., Garnier A., Pineault N. Single-cell level analysis of megakaryocyte growth and development. Differentiation 2012, 83:200-209.
128. Behnke O. An electron microscope study of the rat megacaryocyte. II. Some aspects of platelet release and microtubules. J Ultrastruct Res 1969, 26:111-129.
129. Radley J.M. Extravascular phagocytosis of proerythrocytes following 5-fluorouracil. Scand J Haematol 1980, 24:71-79.
130. Thon J.N., Montalvo A., Patel-Hett S., et al. Cytoskeletal mechanics of proplatelet maturation and platelet release. J Cell Biol 2010, 191:861-874.
131. Lichtman M.A., Chamberlain J.K., Simon W., Santillo P.A. Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release. Am J Hematol 1978, 4:303-312.
132. Scurfield G., Radley J.M. Aspects of platelet formation and release. Am J Hematol 1981, 10:285-296.
133. Kopp H.G., Hooper A.T., Broekman M.J., et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest 2006, 116:3277-3291.
134. Kisucka J., Butterfield C.E., Duda D.G., et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 2006, 103:855-860.
135. Mohle R., Green D., Moore M.A., Nachman R.L., Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 1997, 94:663-668.
136. Pintucci G., Froum S., Pinnell J., Mignatti P., Rafii S., Green D. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb Haemost 2002, 88:834-842.
137. Mazo I.B., Gutierrez-Ramos J.C., Frenette P.S., Hynes R.O., Wagner D.D., von Andrian U.H. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 1998, 188:465-474.
138. Dunois-Larde C., Capron C., Fichelson S., Bauer T., Cramer-Borde E., Baruch D. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 2009, 114:1875-1883.
139. Gel M., Kandasamy S., Cartledge K., Haylock D. Fabrication of micro pore arrays in free standing COC membranes and their application for invitro barrier tissue models. Proc Ieee Micr Elect 2013, 8923:895-898.
140. Kaufman R.M., Airo R., Pollack S., Crosby W.H. Circulating megakaryocytes and platelet release in the lung. Blood 1965, 26:720-731.
141. Trowbridge E.A., Martin J.F., Slater D.N., et al. The origin of platelet count and volume. Clin Phys Physiol Meas 1984, 5:145-170.
142. Paquette R.L., Dergham S.T., Karpf E., et al. Exvivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000, 96:2385-2390.
143. Bertolini F., Battaglia M., Pedrazzoli P., et al. Megakaryocytic progenitors can be generated exvivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 1997, 89:2679-2688.
144. Shpall E.J., Quinones R., Giller R., et al. Transplantation of exvivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8:368-376.
145. Shaw P.H., Gilligan D., Wang X.M., Thall P.F., Corey S.J. Exvivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biol Blood Marrow Transplant 2003, 9:151-156.
146. Matsunaga T., Tanaka I., Kobune M., et al. Exvivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 2006, 24:2877-2887.
147. Sullenbarger B., Bahng J.H., Gruner R., Kotov N., Lasky L.C. Prolonged continuous invitro human platelet production using three-dimensional scaffolds. Exp Hematol 2009, 37:101-110.
148. Pallotta I., Lovett M., Kaplan D.L., Balduini A. Three-dimensional system for the invitro study of megakaryocytes and functional platelet production using silk-based vascular tubes. Tissue Eng Part C Methods 2011, 17:1223-1232.
149. Nakagawa Y., Nakamura S., Nakajima M., et al. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol 2013, 41:742-748.
150. Ghevaert C. Megakaryopoiesis through the ages: from the twinkle in the eye to the fully grown adult. J Thromb Haemost 2013, 11:1727-1729.
151. Bluteau O., Langlois T., Rivera-Munoz P., et al. Developmental changes in human megakaryopoiesis. J Thromb Haemost 2013, 11:1730-1741.
152. Gaur M., Kamata T., Wang S., Moran B., Shattil S.J., Leavitt A.D. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost 2006, 4:436-442.
153. Takayama N., Nishikii H., Usui J., et al. Generation of functional platelets from human embryonic stem cells invitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 2008, 111:5298-5306.
154. Lu S.J., Li F., Yin H., et al. Platelets generated from human embryonic stem cells are functional invitro and in the microcirculation of living mice. Cell Res 2011, 21:530-545.
155. Takayama N., Nishimura S., Nakamura S., et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 2010, 207:2817-2830.
156. Ono Y., Wang Y.H., Suzuki H., et al. Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf. Blood 2012, 120:3812-3821.
157. Masuda S., Li M., Belmonte J.C.I. Invitro generation of platelets through direct conversion: first report in My Knowledge (iMK). Cell Research 2013, 23:176-178.
158. Nakamura S., Takayama N., Hirata S., et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 2014, 14:1-14.